Indocin IV Alternatives Compared
| Indocin IV (indomethacin) | Cosentyx (secukinumab) | Humira (adalimumab) |
|
|---|
| Indocin IV (indomethacin) | Cosentyx (secukinumab) | Humira (adalimumab) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Back Pain, Bursitis, Bartter Syndrome, Ankylosing Spondylitis, Cluster Headaches, Frozen Shoulder, Gitelman Syndrome, Gout - Acute, Langerhans' Cell Histiocytosis, Osteoarthritis... View more |
Prescription only
Cosentyx is used to treat plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis (nr-axSpA), enthesitis-related arthritis, and hidradenitis... View more |
Prescription only
Humira is used to treat multiple inflammatory conditions including rheumatoid arthritis, juvenile arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque... View more |
Related suggestions Ankylosing Spondylitis
|
|||||||||||||||
| More about (indomethacin) | More about Cosentyx (secukinumab) | More about Humira (adalimumab) | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Indocin IV has an average rating of 2.0 out of 10 from a total of 1 ratings on Drugs.com. 0% of reviewers reported a positive effect, while 100% reported a negative effect. |
Cosentyx has an average rating of 6.3 out of 10 from a total of 260 ratings on Drugs.com. 52% of reviewers reported a positive effect, while 30% reported a negative effect. |
Humira has an average rating of 6.4 out of 10 from a total of 705 ratings on Drugs.com. 55% of reviewers reported a positive effect, while 30% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
|
View all Indocin IV side effects |
View all Cosentyx side effects |
View all Humira side effects |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
| Lower cost generic approved |
N/A |
N/A |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Cosentyx prices |
View all Humira prices |
||||||||||||||||
| Dosage Forms | ||||||||||||||||||
|
N/A |
|
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Other indomethacin brands include: Indocin, Indocin SR, Tivorbex |
N/A |
Other adalimumab brands include: Abrilada, Amjevita, Cyltezo, Hadlima, Hulio, Hyrimoz, Idacio, Simlandi, Yuflyma, Yusimry View more | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||
|
4.5 hours |
744 hours |
480 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Category C
Risk cannot be ruled out
Prior To 30 Weeks Gestation
Category D
Positive evidence of risk
Starting At 30 Weeks Gestation See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 429 drugs are known to interact with Indocin IV:
|
A total of 254 drugs are known to interact with Cosentyx:
|
A total of 560 drugs are known to interact with Humira:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
N/A |
January 21, 2015 |
December 31, 2002 |
||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient Resources | ||||||||||||||||||
|
N/A |
||||||||||||||||||
| Professional Resources | ||||||||||||||||||
|
N/A |
||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.